Soleus Capital Management as of March 31, 2026
Portfolio Holdings for Soleus Capital Management
Soleus Capital Management holds 93 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Krystal Biotech (KRYS) | 12.1 | $298M | 1.2M | 258.32 | |
| Celcuity (CELC) | 5.9 | $147M | 1.3M | 114.14 | |
| Tg Therapeutics (TGTX) | 5.4 | $134M | 4.0M | 33.22 | |
| Insulet Corporation (PODD) | 4.8 | $118M | 563k | 209.84 | |
| Novocure Ord Shs (NVCR) | 4.6 | $114M | 11M | 10.90 | |
| United Therapeutics Corporation (UTHR) | 4.5 | $111M | 187k | 592.98 | |
| Praxis Precision Medicines I Com New (PRAX) | 4.3 | $107M | 331k | 322.19 | |
| Vericel (VCEL) | 3.3 | $82M | 2.5M | 32.17 | |
| Alkermes SHS (ALKS) | 2.8 | $70M | 2.0M | 35.36 | |
| Biosante Pharmaceuticals (ANIP) | 2.6 | $63M | 820k | 76.90 | |
| Globus Med Cl A (GMED) | 2.5 | $63M | 730k | 86.16 | |
| Geron Corporation (GERN) | 2.5 | $62M | 42M | 1.49 | |
| Twist Bioscience Corp (TWST) | 2.4 | $58M | 1.2M | 47.52 | |
| Edgewise Therapeutics (EWTX) | 1.8 | $46M | 1.4M | 31.50 | |
| Beta Bionics (BBNX) | 1.8 | $44M | 4.4M | 10.02 | |
| Alnylam Pharmaceuticals (ALNY) | 1.8 | $44M | 132k | 330.87 | |
| Syndax Pharmaceuticals (SNDX) | 1.6 | $40M | 1.7M | 23.36 | |
| Indivior Pharmaceuticals (INDV) | 1.6 | $39M | 1.3M | 30.48 | |
| Neuropace (NPCE) | 1.6 | $39M | 2.9M | 13.15 | |
| Livanova SHS (LIVN) | 1.5 | $37M | 583k | 63.56 | |
| Mirum Pharmaceuticals (MIRM) | 1.5 | $37M | 400k | 92.38 | |
| BioMarin Pharmaceutical (BMRN) | 1.5 | $37M | 651k | 56.49 | |
| Progyny (PGNY) | 1.4 | $35M | 2.1M | 16.98 | |
| Inspire Med Sys (INSP) | 1.2 | $30M | 576k | 51.58 | |
| Edap Tms S A Sponsored Adr (EDAP) | 1.1 | $27M | 7.3M | 3.72 | |
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 1.0 | $25M | 521k | 48.15 | |
| Merck & Co (MRK) | 1.0 | $24M | 203k | 120.29 | |
| Organogenesis Hldgs (ORGO) | 1.0 | $24M | 10M | 2.37 | |
| Natera (NTRA) | 1.0 | $24M | 119k | 199.99 | |
| Axogen (AXGN) | 0.9 | $23M | 679k | 33.13 | |
| Vaxcyte (PCVX) | 0.9 | $22M | 386k | 58.11 | |
| Icon SHS (ICLR) | 0.9 | $21M | 192k | 110.66 | |
| Pharvaris N V (PHVS) | 0.8 | $20M | 702k | 28.25 | |
| Cerus Corporation (CERS) | 0.8 | $20M | 11M | 1.82 | |
| Trevi Therapeutics (TRVI) | 0.8 | $19M | 1.6M | 11.93 | |
| Inhibikase Therapeutics Com New (IKT) | 0.7 | $18M | 11M | 1.68 | |
| Context Therapeutics (CNTX) | 0.7 | $18M | 7.0M | 2.62 | |
| Vir Biotechnology (VIR) | 0.7 | $18M | 2.0M | 8.96 | |
| Xenon Pharmaceuticals (XENE) | 0.7 | $17M | 292k | 58.15 | |
| Travere Therapeutics (TVTX) | 0.7 | $16M | 546k | 29.71 | |
| Tandem Diabetes Care Com New (TNDM) | 0.6 | $15M | 783k | 19.17 | |
| Nurix Therapeutics (NRIX) | 0.6 | $15M | 938k | 15.50 | |
| Urogen Pharma (URGN) | 0.5 | $13M | 727k | 17.98 | |
| Sionna Therapeutics (SION) | 0.5 | $12M | 294k | 40.09 | |
| Corcept Therapeutics Incorporated (CORT) | 0.5 | $12M | 286k | 40.31 | |
| Jade Biosciences Com New (JBIO) | 0.5 | $11M | 797k | 14.05 | |
| Veracyte (VCYT) | 0.4 | $10M | 320k | 32.21 | |
| Adagio Therapeutics (IVVD) | 0.4 | $10M | 7.7M | 1.30 | |
| C4 Therapeutics Com Stk (CCCC) | 0.4 | $10M | 3.8M | 2.63 | |
| Orthopediatrics Corp. (KIDS) | 0.4 | $9.8M | 615k | 15.87 | |
| Arcus Biosciences Incorporated (RCUS) | 0.4 | $9.8M | 452k | 21.60 | |
| Tango Therapeutics (TNGX) | 0.4 | $9.4M | 450k | 20.92 | |
| Evolus (EOLS) | 0.4 | $9.2M | 2.2M | 4.11 | |
| Sophia Genetics Sa Ordinary Shares (SOPH) | 0.4 | $9.2M | 1.9M | 4.95 | |
| Enliven Therapeutics (ELVN) | 0.4 | $9.1M | 231k | 39.20 | |
| Inhibrx Biosciences (INBX) | 0.4 | $8.8M | 131k | 67.23 | |
| Dex (DXCM) | 0.4 | $8.8M | 140k | 62.80 | |
| Septerna (SEPN) | 0.3 | $6.6M | 275k | 24.03 | |
| Avalo Therapeutics Com New (AVTX) | 0.3 | $6.6M | 442k | 14.93 | |
| Biodesix (BDSX) | 0.2 | $6.0M | 417k | 14.50 | |
| Relmada Therapeutics (RLMD) | 0.2 | $5.9M | 842k | 6.96 | |
| Cullinan Oncology (CGEM) | 0.2 | $5.8M | 410k | 14.21 | |
| Immunovant (IMVT) | 0.2 | $5.7M | 230k | 24.84 | |
| Mbx Biosciences (MBX) | 0.2 | $5.3M | 179k | 29.85 | |
| Immunic (IMUX) | 0.2 | $5.0M | 4.5M | 1.11 | |
| Larimar Therapeutics (LRMR) | 0.2 | $4.8M | 1.1M | 4.50 | |
| Eton Pharmaceuticals (ETON) | 0.2 | $4.1M | 166k | 24.68 | |
| Sab Biotherapeutics Com New (SABS) | 0.2 | $4.0M | 1.1M | 3.83 | |
| Procept Biorobotics Corp (PRCT) | 0.2 | $4.0M | 160k | 25.01 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.2 | $3.9M | 80k | 48.20 | |
| Tectonic Therapeutic (TECX) | 0.2 | $3.8M | 122k | 30.91 | |
| Pulmonx Corp (LUNG) | 0.1 | $3.6M | 2.8M | 1.29 | |
| Iovance Biotherapeutics (IOVA) | 0.1 | $3.5M | 1.0M | 3.51 | |
| Argenx Se Sponsored Adr (ARGX) | 0.1 | $2.6M | 3.5k | 730.25 | |
| Karyopharm Therapeutics Com New (KPTI) | 0.1 | $2.5M | 440k | 5.57 | |
| Satellos Bioscience | 0.1 | $2.3M | 414k | 5.63 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.1 | $1.8M | 29k | 62.70 | |
| Inspiremd (NSPR) | 0.1 | $1.7M | 1.0M | 1.63 | |
| Insmed Com Par $.01 (INSM) | 0.1 | $1.7M | 10k | 163.52 | |
| Cytomx Therapeutics (CTMX) | 0.1 | $1.4M | 300k | 4.70 | |
| Cg Oncology (CGON) | 0.1 | $1.4M | 20k | 67.68 | |
| Neogenomics Com New (NEO) | 0.1 | $1.3M | 175k | 7.42 | |
| Quoin Pharmaceuticals Sponsored Ads (QNRX) | 0.0 | $480k | 73k | 6.60 | |
| Cogent Biosciences (COGT) | 0.0 | $385k | 10k | 38.49 | |
| Tyra Biosciences (TYRA) | 0.0 | $383k | 10k | 38.30 | |
| Staar Surgical Com Par $0.01 (STAA) | 0.0 | $374k | 20k | 18.70 | |
| Anaptysbio Inc Common (ANAB) | 0.0 | $333k | 6.0k | 55.46 | |
| Rapport Therapeutics (RAPP) | 0.0 | $313k | 10k | 31.29 | |
| Rigel Pharmaceuticals (RIGL) | 0.0 | $270k | 10k | 27.04 | |
| Zymeworks Del (ZYME) | 0.0 | $250k | 10k | 25.04 | |
| Lb Pharmaceuticals Com Shs (LBRX) | 0.0 | $247k | 10k | 24.66 | |
| Oruka Therapeutics (ORKA) | 0.0 | $245k | 5.0k | 49.05 | |
| Jasper Therapeutics Com New (JSPR) | 0.0 | $242k | 276k | 0.88 |
